NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Do you thinks all patients respond to dcvax?

Hopeforthefuture3,

From Northwest Biotherapeutics webpage:

Most cancer drugs only achieve clinical benefits in a limited percentage of the patients with the type of cancer being targeted (e.g., 25 – 30% of the patients). In contrast, DCVax has achieved clinical benefits (i.e., longer delay in disease progression and longer extension of survival than with standard of care treatment) in over 80% of the patients who have received DCVax in clinical trials to date.

https://nwbio.com/dcvax-technology/